BioLineRx Ltd (BLRX): BioLineRx to Present at 2017 BIO CEO & I...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	145
Posts	27565
Boards Moderated	3
Alias Born	02/07/2004

midastouch017

Re: None

Tuesday, 02/07/2017 7:48:16 AM

Tuesday, February 07, 2017 7:48:16 AM

BioLineRx to Present at 2017 BIO CEO & Investor Conference in New York on February 14

TEL AVIV, Israel, February 7, 2017 /PRNewswire/ --

BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage biopharmaceutical company focused on oncology and immunology, announced today that its Chief Executive Officer, Philip Serlin, and its Chief Business Officer, David Malek, will present a company update at the 2016 BIO CEO & Investor Conference on Tuesday, February 14, 2017 at 10:30 am EST. The conference will be held at the Waldorf Astoria Hotel in New York.

A live webcast of the presentation will be available on BioLineRx's website. A replay will be available one hour after the presentation ends and will be accessible for three months following the presentation.

Investors or potential partners attending the conference who wish to meet with BioLineRx management should contact the BIO Partnering Team at biopartnering@bio.org.